Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased serum N-terminal pro-B-type natriuretic peptide and left ventricle diastolic dysfunction in patients with hepatitis C virus infection.

Journal of viral hepatitis·2012
Same author

HLA-DPbeta chain may confer the susceptibility to hepatitis C virus-associated hypertrophic cardiomyopathy.

International journal of immunogenetics·2008
Same author

Role of hepatitis C virus in cardiomyopathies.

Ernst Schering Research Foundation workshop·2005
Same author

The haplotype block, NFKBIL1-ATP6V1G2-BAT1-MICB-MICA, within the class III-class I boundary region of the human major histocompatibility complex may control susceptibility to hepatitis C virus-associated dilated cardiomyopathy.

Tissue antigens·2005
Same author

Measurements of cardiac troponin T in patients with hypertrophic cardiomyopathy.

Heart (British Cardiac Society)·2003
Same author

Serum cardiac troponin T and plasma brain natriuretic peptide in patients with cardiac decompensation.

Heart (British Cardiac Society)·2002
Same journal

[Advancing cardiovascular prevention : Evidence-based design of healthy and sustainable food environments].

Herz·2026
Same journal

[Effects of air pollution on cardiovascular health].

Herz·2026
Same journal

[Heart and climate].

Herz·2026
Same journal

Multidimensional psychosocial screening in routine cardiac care: preliminary findings from a cross-sectional survey.

Herz·2026
Same journal

[Noise and the heart].

Herz·2026
Same journal

[The cardiovascular exposome: areas of action for prevention and practical cardiology].

Herz·2026
See all related articles

Related Experiment Video

Updated: May 17, 2026

A Modified Simple Method for Induction of Myocardial Infarction in Mice
04:29

A Modified Simple Method for Induction of Myocardial Infarction in Mice

Published on: December 3, 2021

Lessons learned from experimental myocarditis.

A Matsumori1

  • 1Department of Cardiology, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, 160-8402, Tokyo, Japan. amatsumori@clock.ocn.ne.jp

Herz
|October 25, 2012
PubMed
Summary
This summary is machine-generated.

Murine models of viral myocarditis reveal key insights into disease progression and potential treatments. Research identified autoantibodies and immune pathways involved in myocarditis, suggesting new therapeutic targets.

More Related Videos

An Intact Pericardium Ischemic Rodent Model
07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

A Murine Closed-chest Model of Myocardial Ischemia and Reperfusion
13:42

A Murine Closed-chest Model of Myocardial Ischemia and Reperfusion

Published on: July 17, 2012

Related Experiment Videos

Last Updated: May 17, 2026

A Modified Simple Method for Induction of Myocardial Infarction in Mice
04:29

A Modified Simple Method for Induction of Myocardial Infarction in Mice

Published on: December 3, 2021

An Intact Pericardium Ischemic Rodent Model
07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

A Murine Closed-chest Model of Myocardial Ischemia and Reperfusion
13:42

A Murine Closed-chest Model of Myocardial Ischemia and Reperfusion

Published on: July 17, 2012

Area of Science:

  • Cardiology
  • Immunology
  • Virology

Background:

  • Viral myocarditis is a serious heart condition with significant morbidity.
  • Understanding its pathogenesis is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the natural history and pathogenesis of viral myocarditis using murine models.
  • To evaluate diagnostic methods and therapeutic/preventive interventions for viral myocarditis.

Main Methods:

  • Development of murine models of viral myocarditis induced by encephalomyocarditis (EMC) virus.
  • Assessment of autoantibodies, immune cell roles (mast cells), and the renin-angiotensin-aldosterone system.
  • Evaluation of anti-allergic agents, renin-angiotensin-aldosterone system inhibitors, and calcium channel blockers.
  • Analysis of free light chains (FLC) in viral myocarditis.

Main Results:

  • Autoantibodies against cardiac troponin I were identified in PD-1 deficient mice and patients, inducing myocardial dysfunction.
  • Mast cell deficiency and anti-allergic agents showed beneficial effects.
  • Inhibition of the renin-angiotensin-aldosterone system improved viral myocarditis.
  • Certain calcium channel blockers modulated cytokine production and improved the condition.
  • Increased free light chains (FLC) were observed in myocarditis, with exogenous FLC inhibiting viral replication.

Conclusions:

  • Viral myocarditis involves complex immune responses and pathways, including autoantibodies and the renin-angiotensin-aldosterone system.
  • Targeting inflammation, immune responses, and specific molecular pathways offers promise for treating viral myocarditis and reducing organ damage.